...
首页> 外文期刊>Molecular medicine reports >Potential role of microRNA-223-3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics
【24h】

Potential role of microRNA-223-3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics

机译:MicroRNA-223-3P在肝细胞癌肿瘤瘤中的潜在作用:基于数据挖掘和生物信息学的综合研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aims of the present study were to examine the potential role of microRNA-233-3p (miR)-223-3p in the tumorigenesis of hepatocellular carcinoma (HCC), and to investigate its diagnostic accuracy and potential molecular mechanisms. The expression data of miR-223-3p in HCC were obtained from the Gene Expression Omnibus (GEO). Data for the precursor miR-223 were obtained from The Cancer Genome Atlas (TCGA). The diagnostic role of miR-223-3p was identified by the receiver operating curve (ROC), and the diagnostic value of miR-223-3p in HCC was calculated from qualified reports in the literature. In addition, associated data from the GEO, TCGA and qualified experiments were pooled for comprehensive meta-analysis. Genes, which intersected between online prediction databases, natural language processing and differentially expressed genes from TCGA were regarded as potential targets of miR-223-3p in HCC. The Gene Ontology enrichment analysis and the Kyoto Encyclopedia of Genes and Genomes pathways of potential targets were performed using the Database for Annotation, Visualization and Integrated Discovery. The protein-protein interactions were mapped using the Search Tool for the Retrieval of Interacting Genes. Among 15 qualified microarray data sets from GEO, seven showed that a significantly lower level of miR-223-3p was present in the HCC tissues, compared with that in non-cancerous tissues (P 0.80 (P<0.05). The diagnostic accuracy of the precursor miR-223 in TCGA was also calculated (AUC=0.78, P<0.05). Similarly, the precursor miR-223 showed a higher level of downregulation in HCC tissues, compared with that in healthy controls in TCGA (P<0.001). A summary ROC was also calculated as 0.89 (95% CI, 0.85-0.91) in the meta-analysis. A total of 72 potential targets were extracted, mainly involved in the terms 'microRNAs in cancer', 'ATP binding' and 'prostate cancer'. Five potential target genes were considered the hub genes of miR-223-3p in HCC, including checkpoint kinase 1, DNA methyltransferase 1, baculoviral IAP repeat containing 5, kinesin family member 23, and collagen, type I, alpha 1. Based on TCGA, the hub genes were significantly upregulated in HCC (P<0.05). Collectively, these results showed that miR-223-3p may be crucial in HCC carcinogenesis showing high diagnostic accuracy, and may be mediated by several hub genes.
机译:本研究的目的是检查MicroRNA-233-3P(MIR)-223-3P在肝细胞癌(HCC)的肿瘤发生中的潜在作用,并研究其诊断准确性和潜在的分子机制。 HCC中miR-223-3p的表达数据是从基因表达综合征(Geo)获得的。前体MiR-223的数据从癌症基因组Atlas(TCGA)获得。通过接收器操作曲线(ROC)识别MIR-223-3P的诊断作用,并从文献中的合格报告计算了HCC中MIR-223-3P的诊断价值。此外,汇集了来自地理学,TCGA和合格实验的相关数据以进行全面的荟萃分析。在线预测数据库,来自TCGA的自然语言处理和差异表达基因之间的基因被认为是HCC中miR-223-3p的潜在靶标。使用数据库进行注释,可视化和集成发现,进行基因本体浓缩分析和基因的基因和基因组途径的京都植物途径。使用搜索工具映射蛋白质 - 蛋白质相互作用以检索相互作用基因。在来自Geo的15个合格的微阵列数据中,七个显示HCC组织中存在明显较低的MiR-223-3P水平,与非癌组织(P <0.80)相比,HCC组织中存在。诊断准确性还计算了TCGA中的前体MiR-223(AUC = 0.78,P <0.05)。类似,前体MiR-223在HCC组织中显示出更高水平的下调,与TCGA中的健康对照相比(P <0.001)相比。概述ROC还在META分析中计算为0.89(95%CI,0.85-0.91)。提取了72个潜在的靶标,主要涉及癌症中的术语MicroRNA','ATP Tending'和'前列腺癌。将五种潜在的靶基因视为HCC中miR-223-3p的轮毂基因,包括检查点激酶1,DNA甲基转移酶1,含有5,kinesin家族构件23和胶原蛋白的杆状病毒Iap重复,I型,α1 。基于TCGA,HCH在HCC中显着上调了轮毂基因(P <0.05)。集体,这些补充LTS显示MIR-223-3P在HCC癌发生中可能是至关重要的,显示出高诊断准确性,并且可以由几个中心基因介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号